Solid and Pseudopapillary Tumor of the Pancreas—Review and New Insights Into Pathogenesis
Authors:
- Moulin PierreMPMoulin Pierre
- Gigot Jean-FrançoisGJGigot Jean-François
- Weynand BirgitWBWeynand Birgit
- Deprez PierreDPDeprez Pierre
- Rahier JacquesRJRahier Jacques
- Sempoux ChristineSCSempoux Christine
- 1 October 2006
- journal article
- review article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 30 (10) , 1243-1249
Abstract
Solid pseudopapillary tumors (SPT) of the pancreas are rare neoplasms that occur mostly in young women. Despite of a low malignant potential, 10% to 15% of the cases have aggressive behavior with metastatic dissemination possibly leading to death. To date, no pathological factor can reliably predict the outcome of these tumours. Galectin-3, a major actor in the carcinogenesis of pancreatic ductal adenocarcinoma, has not been investigated in SPT. The presence of progesterone receptors is frequently reported in SPT, whereas that of estrogen receptor (ER) is unclear. We studied 5 cases of SPT consisting of 4 pancreatic tumors and 1 metastatic case. The morphological distinctive feature of metastatic nodules was the presence of polygonal or spindle cells with pleiomorphic nuclei and high mitotic count exhibiting a diffuse, infiltrative growth pattern. We found a strong expression of galectin-3 in all SPTs, whereas, interestingly, it was lower in metastatic nodules. Conversely, no galectin-3 expression was found in normal pancreatic endocrine cells or in neuroendocrine tumors. We suggest therefore that galectin-3 is a useful marker to distinguish SPT from neuroendocrine tumor, and also indicator of behavior because its low expression is associated with metastatic spreading. Moreover, the presence of galectin-3 in both SPT and pancreatic ducts rises the hypothesis of a posible ductal origin of these tumors. Specific antibodies for anti-ERalpha and anti-ERbeta demonstrated a strong expression of ERbeta whereas ERalpha was not detected. In conclusion, the present study brings the first evidence of the involvement of galectin-3 in SPT but also brought up clues which allowed to reconcile previously conflicting results on the presence of ER.Keywords
This publication has 33 references indexed in Scilit:
- Differential Expression of Estrogen Receptor β (ERβ) and Its C-Terminal Truncated Splice Variant ERβcx as Prognostic Predictors in Human Prostatic CancerBiochemical and Biophysical Research Communications, 2001
- ERβ Inhibits Proliferation and Invasion of Breast Cancer CellsEndocrinology, 2001
- Comparative Analysis of Galectins in Primary Tumors and Tumor Metastasis in Human Pancreatic CancerJournal of Histochemistry & Cytochemistry, 2001
- Solid-pseudopapillary tumor of the pancreas: its origin revisitedVirchows Archiv, 2000
- Oestrogen receptors – an overviewJournal of Internal Medicine, 1999
- Unbalanced Chromosomal Translocation, der(17)t(13;17)(q14;p11) in a Solid and Cystic Papillary Epithelial Neoplasm of the PancreasAmerican Journal of Surgical Pathology, 1996
- Malignant papillary cystic tumor of the pancreasCancer, 1990
- Estrogen and progesterone receptor determination in the papillary cystic neoplasm of the pancreas. With immunohistochemical and ultrastructural observationsCancer, 1987
- Tumors of the exocrine pancreas in children and adolescentsAmerican Journal of Surgical Pathology, 1983
- Alpha-1-antitrypsin in a malignant mixed mesodermal tumor of the ovaryAmerican Journal of Surgical Pathology, 1981